# Insel Gruppe account plan

> Insel Gruppe is the Bern university hospital group (Inselspital), one of Switzerland's largest care organisations, back to a CHF 134.8 million profit in 2025.

## At a glance

Insel Gruppe is a university hospital group in Bern, Switzerland, made up of the Inselspital university hospital, the rural hospitals Aarberg, Belp and Riggisberg and the Berner Reha Zentrum in Heiligenschwendi; it provides highly specialised medicine and basic care and works closely with the University of Bern. In 2025 group operating income after consolidation was CHF 1,999,192 thousand, EBITDA CHF 279.9 million (14.0 % margin) and group profit CHF 134.8 million, after losses every year since 2021. It treated 55 802 acute inpatients and 893 207 outpatient consultations and employed 8 726 full-time equivalents at end 2025. The foundation Inselspital-Stiftung heads the group, and the Canton of Bern owns the rural hospital real estate company; the group is the largest private employer of the region.

## Business units

- **Spitalbetrieb (hospital operations)** (about 92 % of 2025 group operating income before consolidation (CHF 1,849,844 thousand)): Inpatient and outpatient care, training, teaching and research at the Inselspital and the rural hospitals, run by Insel Gruppe AG. Operating income rose 8.6 % in 2025 while personnel costs fell 3.1 % (excluding the BPK effect); in H1 2026 the segment earned CHF 36.8 million, CHF 10.1 million more than a year earlier.
- **Berner Reha Zentrum AG** (about 2 % of 2025 group operating income before consolidation (CHF 48,200 thousand)): Inpatient and outpatient rehabilitation in Heiligenschwendi, 100 % owned, which returned to a profit in 2025 with lower personnel costs.
- **Inselspital-Stiftung** (about 6 % of 2025 group operating income before consolidation (CHF 112,291 thousand)): The foundation at the top of the group, holding the Inselspital real estate and shareholdings, renting the buildings to Insel Gruppe AG, carrying the group's bonds and the building projects such as the Marie-Colinet-Haus.
- **Spital Netz Bern Immobilien AG**: Owned 100 % by the Canton of Bern and consolidated through a shareholders' agreement; it owns the rural hospital properties and rents them to Insel Gruppe AG.
- **Fonds (funds)** (about 2 % of 2025 group operating income before consolidation (CHF 49,289 thousand)): Separately managed, earmarked assets of Insel Gruppe AG, holding all of the group's securities.

## Strategic priorities

- **Strategie 2035**: Adopted on 13 June 2025, the strategy aims to make Insel Gruppe a pioneer of digital and translational medicine, with five fields of action: staff and culture, patient orientation, medicine of the future, market positioning and networking, and economic efficiency.
- **Reorganisation along patient pathways**: For 2027 the ten medical divisions will be merged into four larger organisational units to promote interprofessional work along patient pathways.
- **Data-based medicine and AI**: Strategie 2035 calls for responsible use of health data and artificial intelligence and for developing the Insel-Campus as a centre of translation, with neurosciences, cardiovascular and oncology as current priorities.
- **Outpatient shift**: The group wants to actively promote outpatient care and bundle it organisationally and spatially, as the new TARDOC and outpatient flat-rate tariffs and EFAS push care toward outpatient settings.
- **Sustaining the margin and staff culture**: Strategie 2035 sets an explicit margin and self-financing goal, while the chair and CEO both put staff motivation and retention at the centre after troubled years.

## Latest results

In the first half of 2026 group profit was CHF 41.9 million against CHF 26.3 million a year earlier, and EBITDA CHF 108.2 million (10.7 % margin). Hospital operations income rose 3.6 % to CHF 1 007.9 million, with outpatient income up 7.4 % to CHF 285.0 million and inpatient income up 1.3 % to CHF 582.8 million. The switch to the new TARDOC outpatient tariff on 1 January 2026 delayed invoicing, pushing operating cash flow to CHF -145.1 million and cash down to CHF 231.5 million. The group gives no numerical guidance and says the pace of change remains high.

## Investments and deals

- **Epic clinical information system**: Introduced in March 2024 to replace more than 50 systems, Epic's project costs total CHF 182.5 million; the chair credits it with efficiency gains such as online appointment booking and fewer no-shows.
- **Marie-Colinet-Haus renovation**: 2025 investment centred on the Marie-Colinet-Haus (CHF 71.3 million), which opened in mid-2026 for gynaecology and obstetrics, neonatology and ophthalmology.
- **Anna-Seiler-Haus main building**: The new main building opened in summer 2023 and is credited with better processes; the old Bettenhochhaus carries a demolition provision.
- **Bond financing**: The group had CHF 910 million of bonds at end 2025, including two Green Bonds; a CHF 250 million bond was repaid or refinanced in H1 2026.

## Challenges and risks

- **New outpatient tariff system**: Converting billing to TARDOC and outpatient flat rates raised accrued income by CHF 227.1 million in H1 2026 and required more short-term debt; a further version of the tariff is due on 1 January 2027.
- **Tariff disputes**: The dispute with the HSK purchasing group over the 2022 and 2023 inpatient base rate is before the Federal Administrative Court, and there is no 2026 outpatient agreement with the ZMT.
- **Regulatory uncertainty**: The KVV revision, EFAS and the second stage of the nursing initiative are pending and their financial effects cannot yet be fully estimated.
- **Workload and skills shortage**: The CEO says workload has increased and the group must create an environment where people stay, after years in which staff spoke of bullying and a climate of fear.
- **Rising medical supply costs**: Medical supplies rose 10.8 % in 2025, driven by drugs, implants and prostheses.

## What leadership says

> "Wir müssen ein Umfeld schaffen, in dem die Leute gerne arbeiten und bei uns bleiben." — Jennifer Diedler, Chair of the Executive Board (CEO), SRF interview, 2026-05-06 (We must create an environment where people like to work and stay with us)

> "Ein offener Diskurs, fernab von Hierarchien, ist entscheidend." — Jennifer Diedler, Chair of the Executive Board (CEO), SRF interview, 2026-05-06 (Open discourse, away from hierarchies, is decisive)

> "Auch andere Abläufe sind mit Epic viel effizienter geworden" — Adrian Schmitter, Chair of the Board of Directors, SRF report on the 2025 results, 2026-03-03 (other processes have also become much more efficient with Epic)

> "Wir müssen das Personal motivieren." — Adrian Schmitter, Chair of the Board of Directors, SRF report on the 2025 results, 2026-03-03 (We must motivate the staff)


## Where a supplier can help

- **Outpatient billing and coding**: The TARDOC conversion that delayed invoicing and the coding backlog behind higher accrued revenue point to revenue cycle, coding and billing process support.
- **Epic-adjacent digital tools**: With Epic in place and Strategie 2035 calling for data-based medicine and AI, suppliers of analytics, AI and integrations around the clinical system fit the medicine-of-the-future priority.
- **Workforce retention and culture**: The CEO and chair's focus on staff motivation and the skills shortage open room for workforce management, rostering, leadership development and employee experience offers.
- **Patient pathway and outpatient processes**: Merging ten divisions into four units along patient pathways and bundling outpatient care call for process consulting, patient flow and scheduling tools.
- **Medical supply procurement**: Medical supply costs rising 10.8 % against an explicit margin goal make procurement, implants and drug cost management relevant.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Konzernrechnung Insel Gruppe 2025 (consolidated annual financial report: financial commentary, corporate governance, remuneration report, consolidated accounts)](https://inselgruppe.ch/fileadmin/Insel_Gruppe/Bilder/Mediendienst/Konzernrechnungen/2025_Konzernrechnung_Insel_Gruppe.pdf)

Annual report · 2026-03-02

- Insel Gruppe is the Bern university hospital group (Inselspital, the rural hospitals, Berner Reha Zentrum), consolidated under the Inselspital-Stiftung foundation; it reports under Swiss GAAP FER and is audited by Ernst & Young AG.
- FY2025 operating income (Betriebsertrag) was CHF 1,999,192 thousand (2024: CHF 1,853,164 thousand); group profit CHF 134.8 million after a CHF 23.7 million loss in 2024; EBITDA CHF 279.9 million, EBITDA margin 14.0 % (2024: 5.5 %).
- The result includes a one-off CHF 49.6 million gain from releasing provisions for financing contributions to the Bernische Pensionskasse (BPK), whose coverage ratio reached 103.2 % at 31.12.2025.
- The Spitalbetrieb (hospital operations) segment swung to a CHF 126.2 million profit from a CHF 50.6 million loss: operating income +CHF 147.2 million (+8.6 %), personnel costs -CHF 33.4 million (-3.1 %, excluding the BPK effect).
- Activity: 55 802 acute inpatients (+3.0 %), 893 207 outpatient consultations (+4.8 %), case mix index up from 1.46 to 1.49; 8 726 full-time equivalents at end 2025 (2024: 8 810).
- Tariff deals with all health insurers for 2025 to 2027 in the university segment added CHF 19.8 million; the HSK (Helsana, Sanitas, KPT) base-rate dispute for 2022 and 2023 is still before the Federal Administrative Court.
- Investment cash flow CHF 94.9 million, of which CHF 71.3 million for the renovation of the Marie-Colinet-Haus (women's and eye clinic); short-term financial debt cut by CHF 80.0 million; bonds outstanding unchanged at CHF 910 million (250 000 TCHF due 07.05.26).
- Strategy 2035 (adopted June 2025) sets five fields of action; leadership changed: Adrian Schmitter chairs the board from November 2025, Prof. Jennifer Diedler became CEO (Vorsitz der Geschäftsleitung) at the start of 2026.
- Headwinds named: the new outpatient tariff system (TARDOC and outpatient flat rates) from 1.1.2026, EFAS, the KVV revision on university-medicine tariffs and the second stage of the nursing initiative.

### [Konzernrechnung Insel Gruppe per 30. Juni 2026 (half-year report H1 2026)](https://inselgruppe.ch/fileadmin/Insel_Gruppe/Bilder/Mediendienst/Konzernrechnungen/Konzernrechnung_Insel_Gruppe_per_30.06.2026.pdf)

Interim report

- H1 2026 group profit CHF 41.9 million (H1 2025: CHF 26.3 million); EBITDA CHF 108.2 million (CHF 98.4 million), EBITDA margin 10.7 % (10.1 %).
- Operating income CHF 1 007.9 million (+CHF 35.4 million, +3.6 %); operating expenses CHF 899.7 million (+2.9 %), growing less than income.
- Inpatient income CHF 582.8 million (+1.3 %), outpatient income CHF 285.0 million (+7.4 %); cell and gene therapies added CHF 6.2 million.
- 28 254 acute inpatients (+0.4 %), 470'796 outpatient consultations (+4.8 %), case mix index 1.48 (H1 2025: 1.47).
- Spitalbetrieb segment profit CHF 36.8 million, up CHF 10.1 million.
- The switch to the new outpatient tariff system (TARDOC and outpatient flat rates) on 1 January 2026 delayed outpatient billing: accrued income jumped from CHF 130.9 million to CHF 358.0 million, operating cash flow was CHF -145.1 million and cash fell to CHF 231.5 million.
- Short-term financial debt rose net CHF 62.2 million, including repayment/refinancing of a CHF 250 million bond.
- Organisation: the ten medical divisions (Medizinbereiche) will be merged into four larger units for 2027; the renovated Marie-Colinet-Haus opened in mid-2026.

### [Strategie 2035 Insel Gruppe](https://www.insel.ch/fileadmin/Insel_Gruppe/Dokumente/Publikationen/ING-Strategie-2035-de.pdf)

Report

- Strategie 2035 was adopted by the board of directors on 13 June 2025; it sets the vision, values and five strategic fields of action for Insel Gruppe.
- The group: founded in 1354, with the Inselspital and sites in Aarberg, Belp, Riggisberg and the Berner Reha Zentrum in Heiligenschwendi; integrated provider of highly specialised medicine and basic care; largest private employer in the region.
- Role: central hub in the cantonal 4+ regions model, engaged in outpatient shift (Ambulantisierung), prevention, rehabilitation, Care at Home and telemedicine.
- Values: respect, excellence, responsibility (Respekt, Exzellenz, Verantwortung).
- Five fields: staff and corporate culture; patient orientation; medicine of the future; market positioning and networking; economic efficiency.
- Medicine of the future: use health data and artificial intelligence responsibly; develop the Insel-Campus as a centre of translation; current focus areas neurosciences, cardiovascular and oncology.
- Economics: generate the margin needed to strengthen self-financing and invest; push for fair framework conditions and remuneration.

### [«Man darf sich nicht vom Renommee eines Arztes blenden lassen» - first interview of Inselspital director Jennifer Diedler (SRF)](https://www.srf.ch/news/international/inselspital-direktorin-man-darf-sich-nicht-vom-renommee-eines-arztes-blenden-lassen)

Executive talk · Jennifer Diedler, Chair of the Executive Board (CEO), Insel Gruppe · 2026-05-06

- First interview of Prof. Jennifer Diedler as head of Insel Gruppe (SRF, 6 May 2026); she is a neurologist who led the Universitätsklinikum des Saarlandes for almost four years.
- Error culture is "Extrem wichtig" (extremely important); she cites aviation as further ahead and wants the organisation to build a safety net so an error does not become fatal.
- Quality and performance, not a doctor's reputation, must be the yardstick: "Man darf sich nicht vom Renommee eines Arztes blenden lassen" (headline quote).
- She saw "wahnsinnige Potenzial" in the Insel: the new main building and the investments made; she found less staff discontent than expected after years of reported "Klima der Angst".
- Culture: shared values respect, excellence and responsibility must be lived by leadership; open discourse beyond hierarchies.
- On the return to profit: workload has risen, but savings also come from efficiency gains, especially in administration; economic results are needed to keep investing in staff amid the skills shortage.

### [Insel-Gruppe schreibt schwarze Zahlen - ist das der Turnaround? (SRF, chair Adrian Schmitter on the 2025 results)](https://www.srf.ch/news/schweiz/zurueck-in-der-gewinnzone-insel-gruppe-schreibt-schwarze-zahlen-ist-das-der-turnaround)

Executive talk · Adrian Schmitter, Chair of the Board of Directors, Insel Gruppe · 2026-03-03

- Adrian Schmitter, chair of Insel Gruppe, on the 2025 return to profit (SRF Regionaljournal, 2-3 March 2026): group profit CHF 134.8 million after losses every year since 2021 (2023: CHF 112.7 million loss).
- Drivers he names: more patients (+3 % inpatient, +4.8 % outpatient), more complex cases that are paid accordingly, the Epic clinical information system introduced in March 2024 and the Anna-Seiler-Haus opened in summer 2023.
- Epic example: patient appointments now fully electronic with self-booking, cutting no-shows.
- Epic project costs now total CHF 182.5 million versus 83 million in the tender (101.6 million external, 52.5 million internal, 28.4 million IT infrastructure).
- The margin is now 14 %, after being below 10 % since 2018; a health economist cited puts the needed minimum at 10 %.
- Schmitter: confirming the result will be harder, but he is convinced "dass das nun der Turnaround ist"; next priorities: re-engaging staff and the "Inselspirit", and efficiency gains from the Marie-Colinet-Haus women's clinic opening in H2.

## Questions about Insel Gruppe

### What is Insel Gruppe?

Insel Gruppe is the university hospital group of Bern, Switzerland, comprising the Inselspital, the rural hospitals Aarberg, Belp and Riggisberg and the Berner Reha Zentrum.

### What is Insel Gruppe's revenue and profit?

In 2025 group operating income was CHF 1,999,192 thousand and group profit CHF 134.8 million, a return to profit after losses each year since 2021. H1 2026 profit was CHF 41.9 million.

### How many employees does Insel Gruppe have?

Insel Gruppe had 8 726 full-time equivalents at the end of 2025 and is the largest private employer of the region.

### Who leads Insel Gruppe?

Prof. Jennifer Diedler has chaired the executive board since the start of 2026, and Adrian Schmitter has chaired the board of directors since November 2025.

### What is Insel Gruppe's strategy?

Strategie 2035 positions the group as a pioneer of digital and translational medicine, focusing on staff culture, patient orientation, medicine of the future, networking and economic efficiency.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
